BON
$1.49
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East.
Intraday
Recent News
Be Wary Of Bon Natural Life (NASDAQ:BON) And Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Bon Natural Life announces distribution agreement with Merrill-Youli Trading
Bon Natural Life (BON) announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youli Trading. The term of the agreement is 36 months with a total contract value of up to US$18 million. Pursuant to the agreement, Merrill-Youli will market, sell and distribute Bon’s Ambroxide and related natural fragrance compounds in the Asia-Pacific region. Merrill-Youli will primarily target the industrial fabric fragrance sector. Bon believes this partnership will help capitalize a leading
Volume On The Nasdaq Was The Third Highest In History On Tuesday. Here Is The Fine Print.
Trading volume on the Nasdaq exchange was huge on Tuesday. It was the third highest volume in its history with over 13 billion shares exchanging hands. For some perspective, that was a level the stock market reached on April 9 when President Donald Trump put a pause on tariffs and the Nasdaq composite soared more than 12%.